Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiographic Control Vs. Ischemia-driven Management of Patients Undergoing Percutaneous Revascularization of the Unprotected Left Main Coronary Artery with Second-generation Drug Eluting Stents: the PULSE Trial

NCT04144881 is registered in ClinicalTrials.gov with A.O.U. Città della Salute e della Scienza as lead sponsor.

NCT NCT04144881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04144881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiographic Control Vs. Ischemia-driven Management of Patients Undergoing Percutaneous Revascularization of the Unprotected Left Main Coronary Artery with Second-generation Drug Eluting Stents: the PULSE Trial
Lead sponsor
A.O.U. Città della Salute e della Scienza
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2019
Completion date
September 3, 2024
Enrollment
606 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary artery disease, left main coronary artery disease, stable chronic angina